IBI-10090

DRUG4 trials

Sponsors

ICON Bioscience Inc

Conditions

CataractsInflammationInflammation Associated With Cataract SurgeryInflammatory Reaction Due to Ocular Lens ProsthesisOcular Inflammation

Phase 2

Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery

TerminatedNCT01048593

ICON Bioscience IncInflammatory Reaction Due to Ocular Lens Prosthesis

Start: 2010-01-31End: 2010-06-30Updated: 2018-12-04

Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients

TerminatedNCT01214174

ICON Bioscience IncOcular Inflammation

Start: 2010-10-31End: 2012-05-31Updated: 2013-09-18

Efficacy and Safety of IBI-10090 in Ocular Surgery Patients

CompletedNCT01606735

ICON Bioscience IncInflammation Associated With Cataract Surgery

Start: 2012-04-30End: 2013-03-31Updated: 2014-09-22

Phase 3

The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery

CompletedNCT02006888

ICON Bioscience IncCataracts, Inflammation

Start: 2014-01-31End: 2014-10-31Updated: 2018-04-23